Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
49 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun) is a pharmaceutical company that manufactures and commercializes active pharmaceutical ingredients, antibiotics and anticancer drugs. The company offers APIs and bulk drugs used in anti-neoplastics. It also offers products for cardiovascular treatment, anti-infection, anti-parasite, endocrine control, immunoinhibitors and anti-depression. Hisun offers active pharmaceutical ingredient such as acarbose, adenosine, bicalutamide, bleomycin a2, b2, bleomycin sulfate, cladribine, cyclophosphmaide, and others. Hisun has research and development facilities in Shanghai and Beijing.

Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed inf

  
Source:
Document ID
GDPH139165D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Zhejiang Hisun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
Zhejiang Hisun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
Zhejiang Hisun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
Zhejiang Hisun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201692
Zhejiang Hisun Pharmaceutical Co., Ltd., Medical Devices Deals, 2010 to YTD 2016111
Zhejiang Hisun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016123
Zhejiang Hisun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deal Details1531
  Venture Financing151
    Sagent Pharma Secures US$40 Million In Series B Financing Round151
  Partnerships161
    GeneriCo Enters into Distribution Agreement with Zhejiang Hisun Pharmaceutical161
    Celsion Enters into Agreement with Zhejiang Hisun Pharma171
    Zhejiang Hisun Pharma Enters into Memorandum of Understanding (MoU) with Sanofi181
    Zhejiang Hisun Pharma to Enter Co-Development Agreement with Ambrx191
    Catalent Pharma Enters Into An Agreement With Zhejiang Hisun Pharma To Develop Biosimilars201
    Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma211
    Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox222
    Pfizer Forms Joint Venture With Zhejiang Hisun Pharma For Generic Medicines242
    Zhejiang Hisun Pharma to Form Joint Venture With Beijing-Based Technology Company261
    Enzon Pharma Enters Into Co-Development Agreement With Zhejiang Hisun Pharma271
    Zhejiang Hisun Enters Into Co-Development Agreement With PharmTak281
  Licensing Agreements291
    Zhejiang Hisun Pharma Enters into Licensing Agreement with Nascent Biotech291
    Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm301
    Zhejiang Hisun Pharma Not To Pursue Option To License ThermoDox For China Market311
    Enzon Pharma Enters Into Licensing Agreement With Zhejiang Hisun Pharma For PEG-SN38322
    Roswell Park Cancer Institute Enters Into Licensing Agreement With Zhejiang Hisun Pharma341
  Equity Offering351
    Zhejiang Hisun Pharma Receives Regulatory Approval for Private Placement of Shares351
    Zhejiang HISUN Pharma Plans Private Placement For US$203 Million361
  Debt Offering371
    Zhejiang Hisun Pharma Prices Private Placement of Bonds for USD184 Million371
    Zhejiang Hisun Pharma to Raise USD128.6 Million in First Tranche of Public Offering of Bonds381
    Zhejiang Hisun Pharma Announces Private Placement Of Notes For Up To US$327 Million391
    Zhejiang Hisun Pharma Announces Public Offering Of Bonds401
  Acquisition411
    Zhejiang Hisun Pharma to Acquire 68% Stake in China Based Pharma Company for USD24.5 Million411
    Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma421
    Zhejiang Hisun Pharma to Acquire 15% Stake in Zhejiang-Based Pharma Company for USD12 Million431
    Zhejiang Hisun Pharma Acquires Respirics, Respiratory Drug Developer441
    Zhejiang Hisun To Invest In Photolitec451
Zhejiang Hisun Pharmaceutical Co., Ltd. - Key Competitors461
Key Employees471
Locations And Subsidiaries481
  Head Office481
  Other Locations &Subsidiaries481
Appendix491
  Methodology491
  About GlobalData491
  Contact Us491
  Disclaimer491

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zhejiang-Hisun-Pharmaceutical-Co-Ltd-600267-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10101>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zhejiang-Hisun-Pharmaceutical-Co-Ltd-600267-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10101>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research